Cell and Gene therapies are among today’s most cutting-edge scientific approaches to treating or curing life-threatening diseases such as cancers or genetic disorders. Delivering those innovative therapeutic products presents unique unmet needs in quality testing. Traditional microbiological methods (14-day sterility testing, 28-day mycoplasma testing), which were initially designed for less time-sensitive applications, are no longer suitable.

Do Your Cellular Therapies Have High-Performance Quality Control?
Overcoming complex manufacturing challenges and ensuring the quality, safety, and efficacy of Cell and Gene therapies administered to patients is critical. Your innovative products demand trusted testing systems.

bioMérieux has been supporting Cell and Gene therapy developers with the BACT/ALERT^® system, providing automated rapid sterility testing results in days. Together with a comprehensive portfolio of rapid and easy-to-use detection solutions, bioMérieux brings overall efficiencies to the manufacturing process through simplified workflows and fast, accurate, actionable results to ensure patient safety.

When a patient relies on your product, there's no time to lose. Streamlined Quality Control testing specific to cell and gene therapies yields safe, rapid, and efficient results.

Discover bioMérieux’s proven portfolio of value-added solutions.

Visit the bioMérieux website here or use the Request Information button below to connect directly with the supplier.